Partial laminin α2 chain restoration in α2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation

Journal of Cell Biology

Volumn 133, Issue 1, 1996, Pages 185-197

  Vilquin, Jean Thomas ^a   Kinoshita, Ikuo ^a   Roy, Brigitte ^a   Goulet, Marlyne ^a   Engvall, Eva ^b,c   Tomé, Fernando ^d   Fardeau, Michel ^d   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b BURNHAM INSTITUTE   (United States)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LAMININ; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT; NOTEXIN; SNAKE VENOM;

AGE; ALLOTRANSPLANTATION; ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CELL IMMORTALIZATION; CELL TRANSPLANTATION; CONTROLLED STUDY; HYBRID CELL; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; BIOSYNTHESIS; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; GAMMA RADIATION; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE MUTANT; RADIATION EXPOSURE; SKELETAL MUSCLE;

ANIMALIA; MUS MUSCULUS;

AGE FACTORS; ANIMALS; BETA-GALACTOSIDASE; CELL TRANSPLANTATION; CELLS, CULTURED; ELAPID VENOMS; FEMALE; GAMMA RAYS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LAMININ; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; TACROLIMUS;

EID: 0029664438     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.133.1.185     Document Type: Article

References (56)

1. Andre, F., P. Filippi, and H. Feracci. 1994 Merosin is synthesized by thyroid cells in primary culture irrespective of cellular organization. J. Cell Sci. 107, 183-193.
2. Anton, E S., A.W Sandrock, and W.D Matthew. 1994. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo evidence using an antibody to merosin, ARM-1. Dev Biol. 164:133-146.
3. Arahata, K., Y.K. Hayashi, R. Koga, K. Goto, J.H. Lee, Y Miyagoe, H. Ishii, T Tsukahara, S. Takeda, M. Woo, I. Nonaka, T. Matsuzaki, and H Sugita 1993. Laminin in animal models for muscular dystrophy. Defect of laminm M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice Proc. Japan Acad. Ser B:259-264.
4. Asselin, I., M. Tremblay, J.-T. Vilquin, B. Guérette, R. Roy, and J.P. Tremblay 1995. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve 18:980-986.
5. Bradley, W.G., and M. Jenkison. 1973. Abnormalities of peripheral nerves in murine muscular dystrophy. J. Neurol. Sci. 18:227-247.
6. Burgeson, R.E., M. Chiquet, R. Deutzmann, P. Ekblom, J. Engel, H Kleinman, G.R. Martin, G Meneguzzi, M Paulsson, J. Sanes, R Timpl, K. Tryggvason, Y. Yamada, and P.D. Yurchenko. 1994. A new nomenclature for the laminins Matrix Biol. 14 209-211.
7. Campbell, K.P. 1995. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80:675-679
8. Dubowitz, V., and M. Fardeau. 1995 Workshop report: proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. Neuromusc Disord. 5:253-258.
9. Ehrig, K., I. Leivo, W S. Argraves, E. Ruoslahti, and E. Engvall 1990. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein Proc. Natl. Acad. Sci. USA. 87:3264-3268.
10. Engvall, E. 1993. Laminin variants: why, where and when? Kidney Int 43:2-6.
11. Engvall, E., D. Earwicker, A. Day, D. Muir, M. Manthorpe, and M. Paulsson. 1992. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 schwannoma cells. Exp Cell Res. 198:115-123.
12. Grounds, M., T.A. Partridge, and J.C. Sloper. 1980. The contribution of exogenous cells to regenerating skeletal muscle: an isoenzyme study of muscle allografts in mice. J. Pathol. 132:325-341.
13. Guérette, B., I. Asselin, J.-T. Vilquin, I. Kinoshita, R. Roy, and J P. Tremblay. 1995. Lymphocyte infiltration following allo and xeno myoblast transplantation in mdx mice. Muscle Nerve. 18:39-51.
14. Hallauer, J.B., H L. Bradshaw, and K.E.M. Hasting. 1993. Complex fiber-type-specific expression of fast skeletal muscle troponin I gene constructs in transgenic mice. Development. 119:691-701.
15. Harris, J.B., M.A. Johnson, and E. Karlsson. 1975. Pathological responses of rat skeletal muscle to a single subcutaneous injection of a toxin from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin. Exp Pharm Phys. 2 383-404.
16. Hayashi, Y.K., E. Engvall, E. Arikawa-Hirasawa, K. Goto, R Koga, I. Nonaka, H. Sugita, and K. Arahata. 1993. Abnormal localization of laminin subunits in muscular dystrophies. J. Neurol. Sci. 119:53-64.
17. Hayashi, Y.K., R. Koga, T. Tsukahara, H. Ishii, T. Matsuishi, Y. Yamashita I Nonaka, and K. Arahata. 1995. Deficiency of laminin α2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy Muscle Nerve. 18:1027-1030.
18. Helbling-Leclerc, A., X. Zhang, H. Topaloglu, C. Cruaud, F. Tesson, J. Weissenbach, F.M.S. Tomé, K. Schwartz, M Fardeau, K Tryggvason, and P Guicheney. 1995 Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nature Genet. 11:216-218
19. Hillaire, D., A. Leclerc, S. Fauré, H. Topaloglu, N Chiannilkulchai, P Guicheney, L. Grinas, P. Legos, J. Philpot, T. Evangelista, M -C. Routon, M Mayer, J.-F. Pellissier, B. Estournet, A. Barois, F. Hentati, N Feingold, J.S Beckmann, V. Dubowitz, F.M.S. Tomé, and M. Fardeau. 1994. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum. Mol. Genet. 3:1657-1661.
20. Huard, J., S. Verreault, R. Roy, and J.P Tremblay. 1994. High efficacy of muscle regeneration following human myoblast transplantation in SCID mice J. Clin. Invest. 93:586-599.
21. b-tsA58 transgenic mouse. Proc. Natl. Acad. Sci USA 88:5096-5100.
22. Kinoshita, I., J. Huard, and J.P Tremblay. 1994a Utilization of myoblasts from a transgenic mouse to evaluate the efficacy of myoblast transplantation. Muscle Nerve 17:975-980.
23. Kinoshita, I., J.-T. Vilquin, C. Gravel, R. Roy, and J.P. Tremblay. 1995. Myoblast allotransplantation in primates. Muscle Nerve. 18:1217-1218.
24. Kinoshita, I., J.-T. Vilquin, B. Guérette, I. Asselin, R. Roy, and J.P. Tremblay. 1994b. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve. 17:1407-1415.
25. Law, P.K. 1982. Beneficial effects of transplanting normal limb-bud mesenchyme into dystrophic mouse muscles Muscle Nerve. 5:619-627.
26. Law, P.K., T.G. Goodwin, and H.-J. Li. 1988a. Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. Transpl. Proc. 20 (Suppl. 3):1114-1119.
27. Law, P.K., T.G. Goodwin, and M G. Wang. 1988b. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve. 11:525-533.
28. Leivo, I., and E. Engvall. 1988. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad. Sci. USA. 85:1544-1548.
29. Lin, Z., M.-H. Lu, T. Schultheiss, J. Choi, S. Holtzer, C. DiLullo, D.A. Fischman, and H. Holtzer. 1994. Sequential appearance of muscle-specific proteins in myoblasts as a function of time after cell division: evidence for a conserved myoblast differentiation program in skeletal muscle Cell Motil. & Cytoskeleton 29:1-19.
30. Madrid, R E., E. Jaros, M.J. Cullen, and W.G. Bradley. 1975. Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature (Lond). 257:319-321
31. Michelson, A.M., E S. Russell, and P.J. Harman. 1955 Dystrophia muscularis: a hereditary primary myopathy in the house mouse. Proc. Natl. Acad. Sci. USA. 41:1079-1084.
32. Montgomery, A., and L Swenarchuk. 1977 Dystrophic mice show age related muscle fibre and myelinated axon losses. Nature (Lond.) 267:167-169.
33. Morgan, J.E., J.R. Beauchamp, C.N. Pagel, M. Peckham, P Ataliotis, P S Jat, M.D. Noble, K. Farmer, and T A. Partridge. 1994 Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol 162:486-498
34. Morgan, J.E., E.P. Hoffman, and T.A. Partridge. 1990. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 111:2437-2449.
35. Morgan, J.E., S.E. Moore, F.S. Walsh, and T A. Partridge. 1992. Formation of skeletal muscle in vivo from the mouse C2 cell line. J. Cell Sci. 102:779-787.
36. Morgan, J.E., C.N. Pagel, T. Sherratt, and T.A. Partridge. 1993. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J Neurol Sci. 115:191-200.
37. Partridge, T.A., M. Grounds, and J.C. Sloper. 1978. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature (Lond.). 273:306-308
38. Partridge, T.A., J.E. Morgan, G.R. Coulton, E.P. Hoffman, and L.M. Kunkel. 1989. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature (Lond.). 337:176-179.
39. Pavlath, G.K., T.A. Rando, and H.M. Blau. 1994. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol. 127:1923-1932.
40. Philpot, J., C. Sewry, J. Pennock, and V. Dubowitz. 1995. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromusc. Disord. 5:301-305.
41. Rantanen, J., T. Hurme, R. Lukka, J. Heino, and H. Kalimo 1995. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab. Invest. 72:341-347.
42. Sewry, C.A., J. Philpot, D. Mahony, L.A. Wilson, F. Muntoni, and V. Dubowitz. 1995. Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 5:307-316
43. Sunada, Y., S.M. Bernier, C.A. Kozak, Y. Yamada, and K.P. Campbell. 1994. Deficiency of Merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem. 269:13729-13732.
44. 2J mice Hum Mol. Genet. 6:1055-1061.
45. Tomé, F M.S., T. Evangelista, A. Leclerc, Y. Sunada, E. Manole, B. Estournet, A. Barois, K.P. Campbell, and M. Fardeau. 1994. Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. Paris 317:351-357
46. Tremblay, J.P., F. Malouin, R. Roy, J. Huard, J P. Bouchard, A. Satoh, and C.L. Richards. 1993. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplantation. 2:99-112.
47. Vilquin, J.-T., I. Asselin, B. Guérette, I. Kinoshita, R. Roy, and J.P. Tremblay. 1995a. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation. 59:422-426.
48. Vilquin, J.-T., B. Guérette, I. Kinoshita, B. Roy, M. Goulet, C. Gravel, R. Roy, and J.P. Tremblay. 1995b. FK506 immunosuppression to control the immune reactions triggered by first generation adenovirus-mediated gene transfer. Hum. Gene Therapy. 6:1391-1401.
49. Vilquin, J.-T., E Wagner, I. Kinoshita, R. Roy, and J.P. Tremblay. 1995c. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J. Cell Biol. 131:975-988.
50. Vuolteenaho, R., M. Nissinen, K. Sainio, M. Byers, R. Eddy, H. Hirvonen, T.B. Shows, H. Sariola, E. Engvall, and K. Tryggvason. 1994. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J. Cell Biol. 124:381-394.
51. Wakeford, S., D.J. Watt and T.A. Partridge. 1991. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14:42-50.
52. Watt, D.J., J.E. Morgan, and T.A. Partridge. 1984. Long term survival of allografted muscle precursor cells following a limited period of treatment with cyclosponn A. Clin. Exp. Immunol. 55:419-426.
53. Wernig, A., A. Irintchev, A. Hartling, G. Stephan, K. Zimmerman, and A. Starzinski-Powitz. 1991. Formation of new muscle fibres and tumours after injection of cultured myogenic cells J Neurocytol. 20:982-997
54. Wirtz, P., H. Loermans, and E. Rutten. 1982 Effects of irradiation on regeneration in dystrophic mouse leg muscles. Br J. Exp Path. 63:671-679.
55. Xu, H., P. Christmas, X.-R. Wu, U M. Wewer, and E. Engvall. 1994a Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. USA. 91:5572-5576.
56. Xu, H., X.-R. Wu, U.M. Wewer, and E. Engvall. 1994b. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama2) gene. Nat. Genet. 8: 297-302.